Efficacy of Ginseng for Patients on Regorafenib

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a randomized, multi-center phase II study of ginseng in colorectal cancer patients treated with regorafenib to determine if ginseng will reduce fatigue in this patient population and improve adherence to regorafenib. Ninety (90) subjects will be enrolled and randomized using a 2:1 allocation, with 60 subjects enrolled in the regorafenib + ginseng group and 30 enrolled in the regorafenib + no ginseng group.
Epistemonikos ID: 422ec50c99c5863db6d6e4c16ab027ced5e7131d
First added on: May 12, 2024